Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8636781rdf:typepubmed:Citationlld:pubmed
pubmed-article:8636781lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:8636781lifeskim:mentionsumls-concept:C0024312lld:lifeskim
pubmed-article:8636781lifeskim:mentionsumls-concept:C0746883lld:lifeskim
pubmed-article:8636781lifeskim:mentionsumls-concept:C0677881lld:lifeskim
pubmed-article:8636781pubmed:issue2lld:pubmed
pubmed-article:8636781pubmed:dateCreated1996-7-9lld:pubmed
pubmed-article:8636781pubmed:abstractTextFebrile grade four (ie, < or = 500/microL) neutropenia (FN) is a frequent life-threatening complication of cancer chemotherapy. Although its incidence correlates to the dose of chemotherapy, FN may occur after almost any cytotoxic regimen. At present, there is no predictive method to identify patients who will experience FN.lld:pubmed
pubmed-article:8636781pubmed:languageenglld:pubmed
pubmed-article:8636781pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8636781pubmed:citationSubsetIMlld:pubmed
pubmed-article:8636781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8636781pubmed:statusMEDLINElld:pubmed
pubmed-article:8636781pubmed:monthFeblld:pubmed
pubmed-article:8636781pubmed:issn0732-183Xlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:BironPPlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:PhilipTTlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:FreyerGGlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:LasserEElld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:BlayJ YJYlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:ChauvinFFlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:AnglaresAAlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:Le CesneAAlld:pubmed
pubmed-article:8636781pubmed:authorpubmed-author:BouhourDDlld:pubmed
pubmed-article:8636781pubmed:issnTypePrintlld:pubmed
pubmed-article:8636781pubmed:volume14lld:pubmed
pubmed-article:8636781pubmed:ownerNLMlld:pubmed
pubmed-article:8636781pubmed:authorsCompleteYlld:pubmed
pubmed-article:8636781pubmed:pagination636-43lld:pubmed
pubmed-article:8636781pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:meshHeadingpubmed-meshheading:8636781-...lld:pubmed
pubmed-article:8636781pubmed:year1996lld:pubmed
pubmed-article:8636781pubmed:articleTitleEarly lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.lld:pubmed
pubmed-article:8636781pubmed:affiliationCentre Léon Bérard, Lyon, France.lld:pubmed
pubmed-article:8636781pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8636781lld:pubmed